TY  - JOUR 
AU  - Nieto Jiménez, Celia
AU  - Vega Moreno, Milena Amparo
AU  - Martín del Valle, Eva María
PY  - 2021
SN  - 2072-6694
UR  - http://hdl.handle.net/10366/169108
AB  - Despite the advances made in the fight against HER2-positive breast cancer, the need for
less toxic therapies and strategies that avoid the apparition of resistances is indisputable. For this
reason, a targeted nanovehicle for paclitaxel and...
LA  - eng
PB  - MDPI
KW  - Breast cancer
KW  - HER2-overexpression
KW  - Drug delivery system
KW  - Polydopamine nanoparticles
KW  - Paclitaxel
KW  - Trastuzumab
TI  - Nature-inspired nanoparticles as paclitaxel targeted carrier for the treatment of her2-positive breast cancer
DO  - 10.3390/cancers13112526
T2  - Cancers
VL  - 13
M2  - 2526
ER  -